Apr 5 |
I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference
|
Apr 2 |
I-Mab Announces Closing of the Divestiture of Business Operations in China
|
Mar 18 |
I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 14 |
I-Mab Biopharma GAAP EPS of -$1.01 beats by $0.76
|
Mar 14 |
I-Mab Reports Full Year 2023 Financial Results and Business Update
|
Feb 21 |
Q4 2023 Summit Therapeutics Inc Earnings Call
|
Feb 18 |
I-Mab: Trading Below Net Cash With Multiple Upside Options
|
Feb 7 |
Looking Into I-MAB's Recent Short Interest
|
Feb 7 |
I-Mab to divest Chinese assets amid rising geopolitical tensions
|
Feb 7 |
UPDATE 2-Biotech firm I-Mab to divest China operations, shift focus to US
|